POST Online Media Lite Edition


NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

Canadian doctors discover first antibiotic in 30 years

Staff Writer |
Canadian scientists have discovered the first new antibiotic in 30 years and preliminary research suggests it could be a major advance in fighting superbugs, Canadian media reported.

Article continues below

The research by two doctors at St. Boniface Hospital in Winnipeg in the province of Manitoba was published in the Canadian Journal of Physiology and Pharmacology.

Although clinical tests need to be completed and the drug, named PEG-2S, is years away from being available to the public, it shows promise in tackling at least two of the superbugs that the World Health Organization describes as one of the greatest threats to world population.

Superbugs are bacteria that have developed resistance to antibiotics.

“It is predicted that by about 2030, all of the antibiotics that we use today to treat bacteria and bacterial infections will no longer be effective,” Dr. Grant Pierce, executive director of research at St. Boniface, said, as reported by CTV News. The research was conducted by Pierce and Dr. Pavel Dibrov.

In preliminary tests, the drug was effective against the sexual disease chlamydia, pneumonia, Legionnaires’ disease, gingivitis and periodontitis, the Canadian Broadcasting Corporation reported.

The two doctors have applied for patent approval from the U.S. Food and Drug Administration. They then plant to begin testing on animals and, provided those tests go well, trials on humans.

What to read next

U.S. doctors still over-prescribing drugs
NTU scientists discover way to improve effectiveness of antibiotics
The more antibiotics, the more obese children